对于重症儿科患者的流体治疗的ROSE框架
Romina Aparecida Dos Santos Gomes1,2, Manu L N G Malbrain3,4,5, Adriana Teixeira Rodrigues1,2
1Department of Pediatrics, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Anaesthesiology intensive therapy
|March 4, 2026
概括
ROSE框架适用于儿科流体管理,显示了个性化护理的可行性和潜力. 虽然液体积累是相似的,但训练后粘附性得到改善.
科学领域:
- 儿科重症监护医学 儿科重症监护医学
- 流体管理策略 流体管理策略
- 临床框架实施实施
背景情况:
- 重症儿童经常经历液体过载,影响结果.
- 复苏,优化,稳定,疏散 (ROSE) 框架为流体治疗提供了一个结构化的方法.
- 评估ROSE框架在儿科重症监护中的适用性至关重要.
研究的目的:
- 评估ROSE框架对重症儿科患者流体管理的可行性和影响.
- 评估框架在预防液体积累和改善临床结果方面的有效性.
- 在ROSE框架的不同阶段对流体积累百分比 (FA%) 进行比较.
主要方法:
- 一项准实验性研究比较了机械通风,血管活性依赖儿童的回顾和前性队列 (n=122).
- 为潜在队伍实施关于ROSE引导流体管理的结构化培训.
- 测量结果包括液体积累百分比 (FA%),机械通风持续时间,PICU停留时间和置换疗法 (RRT) 的需要.
主要成果:
- 流体积累百分比 (FA%) 在多个时间点的回顾和前性队列之间保持相似.
- 在复苏,优化和疏散阶段,FA%相当于复苏,优化和疏散阶段,但在预期队列中稳定期间更高.
- 在ROSE框架实施后,对FA%目标的坚持从67.9%增加到72.4%;其他临床结果类似.
结论:
- ROSE框架是一个可行的方法,用于管理重症儿科患者的流体治疗.
- 它为控制液体积累提供了有价值的基准测试,并显示了个性化液体管理的前景.
- 建议在以前没有接触过ROSE框架的中心进行进一步的验证.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
817
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
817
Acute Respiratory Failure-V
768
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
768
Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
414
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
414
Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Continuous Renal Replacement Therapy
2.3K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.3K


